These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1850307)

  • 41. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single dose anti-Rh(D) immunoglobulin for chronic immune thrombocytopenic purpura.
    Gokalp A; Kanra T; Oguz A; Gultekin A; Turkay S
    Indian Pediatr; 1990 Aug; 27(8):859-61. PubMed ID: 2177730
    [No Abstract]   [Full Text] [Related]  

  • 43. Alternation of two doses of intravenous gammaglobulin in the maintenance treatment of patients with immune thrombocytopenic purpura: more is not always better.
    Bussel JB; Fitzgerald-Pedersen J; Feldman C
    Am J Hematol; 1990 Mar; 33(3):184-8. PubMed ID: 1689103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fc receptor blockade and immune thrombocytopenic purpura.
    Bussel JB
    Semin Hematol; 2000 Jul; 37(3):261-6. PubMed ID: 10942220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD; Goldsmith G
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [High-dose immunoglobulin infusions in idiopathic thrombopenic purpura].
    Wagner HP; Barandun S; Hirt A; Imbach P
    Presse Med; 1983 Nov; 12(41):2612-4. PubMed ID: 6228798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children.
    Son DW; Jeon IS; Yang SW; Cho SH
    J Pediatr Hematol Oncol; 2008 Aug; 30(8):598-601. PubMed ID: 18799936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins.
    Rodeghiero F; Schiavotto C; Castaman G; Vespignani M; Ruggeri M; Dini E
    Haematologica; 1992; 77(3):248-52. PubMed ID: 1330848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review: immune thrombocytopenic purpura: an update for immunohematologists.
    Sandler SG
    Immunohematology; 2004; 20(2):112-7. PubMed ID: 15373659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D).
    Salama A; Kiefel V; Amberg R; Mueller-Eckhardt C
    Blut; 1984 Jul; 49(1):29-35. PubMed ID: 6430368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A clinical study of intravenous immunoglobulin therapy for childhood idiopathic thrombocytopenic purpura.
    Lin DT; Hwu WL; Lin KH; Lin KS
    Taiwan Yi Xue Hui Za Zhi; 1989 Mar; 88(3):244-7. PubMed ID: 2794922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use and mechanism of action of intravenous immunoglobulin in the treatment of immune haematologic disease.
    Bussel JB; Hilgartner MW
    Br J Haematol; 1984 Jan; 56(1):1-7. PubMed ID: 6367804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
    Blanchette V; Carcao M
    Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of idiopathic thrombocytopenic purpura in adults with high-dosage immunoglobulins].
    Busch FW; Ostendorf P; Schnaidt M; Wernet P; Waller HD
    Dtsch Med Wochenschr; 1983 Aug; 108(34):1284-7. PubMed ID: 6684019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients.
    Gaines AR
    Blood; 2000 Apr; 95(8):2523-9. PubMed ID: 10753830
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune thrombocytopenia purpura: a pilot study of staphylococcal protein A immunomodulation in refractory patients.
    Guthrie TH; Oral A
    Semin Hematol; 1989 Apr; 26(2 Suppl 1):3-9. PubMed ID: 2727721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravenous immunoglobulin therapy for idiopathic thrombocytopenic purpura.
    Atrah HI; Crawford RJ; Gabra GS; Mitchell R
    Scott Med J; 1986 Oct; 31(4):231-3. PubMed ID: 3563461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody.
    Clarkson SB; Bussel JB; Kimberly RP; Valinsky JE; Nachman RL; Unkeless JC
    N Engl J Med; 1986 May; 314(19):1236-9. PubMed ID: 2939345
    [No Abstract]   [Full Text] [Related]  

  • 59. [High-dose immunoglobulin therapy in autoimmune diseases].
    Fateh-Moghadam A; Besinger U; Wick M
    Immun Infekt; 1984 Apr; 12(2):129-33. PubMed ID: 6085502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoclonal antibody 197 (anti-Fc gamma RI) infusion in a patient with immune thrombocytopenia purpura (ITP) results in down-modulation of Fc gamma RI on circulating monocytes.
    Ericson SG; Coleman KD; Wardwell K; Baker S; Fanger MW; Guyre PM; Ely P
    Br J Haematol; 1996 Mar; 92(3):718-24. PubMed ID: 8616043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.